If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennon Regulatory News (PNN)

Share Price Information for Pennon (PNN)

Share Price is delayed by 15 minutes
Get Live Data
474.20    -5.60 (-1.17%)
Bid:
474.00
Ask:
475.00
Spread: 1.00 (0.211%)
Market Cap: £2.24b
PNN Live PriceLast checked at - London Stock Exchange

Intraday Pennon Share Chart

EMTN Programme: Publication of Final Terms

Today 07:00

RNS Number : 4026L
Pennon Group PLC
07 July 2026
 

THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED AS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7(1) OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED (THE "UK MARKET ABUSE REGULATION").

7 July 2026

 

Pennon Group plc - LEI: 213800V1CCTS41GWH423

South West Water Finance Plc - LEI: 213800OV68U446W4NV89South West Water Limited - LEI: 213800FR2VAOKRYRHX45

EMTN Programme: Successful pricing of GBP 250mn 6.000 per cent. Fixed Rate Guaranteed Notes due 2035 and GBP 100mn 3.806 per cent. Index-Linked Guaranteed Notes due 2041 (together the "New Notes")

South West Water Finance Plc (the "Issuer") has successfully priced a debt transaction of New Notes that will be issued under the Issuer's EMTN programme established in 2024, pursuant to a base prospectus dated 21 August 2025 (as supplemented on 1 December 2025 and 18 June 2026) (the "Base Prospectus" and the proposed "Issuance"). The Base Prospectus is available on Pennon Group plc's website at: https://www.pennon-group.co.uk/investor-information/debt-investors.

The New Notes will be guaranteed by South West Water Limited (the "Guarantor") and the proceeds from the Issuance will be on-lent by the Issuer to the Guarantor [and used for its general corporate purposes][1]. Application is to be made for the New Notes to be admitted to trading on the Main Market of the London Stock Exchange plc.

The New Notes, which will be issued on 16 July 2026, are subject to final legal documentation and customary closing conditions.

For further information, please contact Chris Tregenna, Group Treasurer, on 07733 312479.

DISCLAIMER

This announcement does not constitute or form part of an offer to sell or the solicitation of an offer to sell or subscribe for or otherwise acquire any securities (including, without limitation, the New Notes). Any investment decision to purchase any New Notes should be made solely on the basis of the information contained in the Base Prospectus and the final terms to be published by the Issuer relating to the New Notes, and no reliance is to be placed on any information given or any representations made in connection with the New Notes other than those contained in the Base Prospectus and the final terms to be published by the Issuer relating to the New Notes. This announcement is an advertisement and is not a prospectus for the purposes of the Prospectus Rules: Admission to Trading on a Regulated Market sourcebook. The Base Prospectus is available, and the final terms will, when published, be available on Pennon Group plc's website at: https://www.pennon-group.co.uk/investor-information/debt-investors.

In particular, this announcement is not for distribution in the United States and the notes offered by the Base Prospectus have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements. Subject to certain exceptions, the securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States of America, as such terms are defined in Regulation S under the Securities Act. There will be no public offering of the New Notes in the United States.

Your right to access this service is conditional upon complying with the above requirement.

END


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUPUBUMUPQGRM
Date   Source Headline
8th Jul 20267:00 amRNSEMTN Programme: Publication of Final Terms
1st Jul 20267:00 amRNSTotal Voting Rights
22nd Jun 202610:55 amRNSDirector/PDMR Shareholding
18th Jun 20262:53 pmRNSEMTN: Publication of Supplementary Prospectus
16th Jun 20267:00 amRNSPublication of Annual Report and Accounts 2026
10th Jun 20267:00 amRNSFull Year Results 2025/26
1st Jun 20267:00 amRNSTotal Voting Rights
29th May 20262:06 pmRNSHolding(s) in Company
20th May 20261:48 pmRNSDirector/PDMR Shareholding
14th May 202612:03 pmRNSDirector/PDMR Shareholding
6th May 20262:12 pmRNSAdmission to Trading
1st May 20264:31 pmRNSHolding(s) in Company
1st May 20267:00 amRNSTotal Voting Rights
30th Apr 20263:11 pmRNSHolding(s) in Company
27th Apr 20264:34 pmRNSHolding(s) in Company
24th Apr 20263:29 pmRNSHolding(s) in Company
22nd Apr 20264:30 pmRNSHolding(s) in Company
21st Apr 20261:17 pmRNSDirector/PDMR Shareholding
20th Apr 20264:09 pmRNSHolding(s) in Company
14th Apr 20264:24 pmRNSRescheduled Full-Year Results Date
1st Apr 20267:00 amRNSTotal Voting Rights
20th Mar 20262:06 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTrading Statement
2nd Mar 20267:00 amRNSTotal Voting Rights
23rd Feb 202612:58 pmRNSDirector/PDMR Shareholding
10th Feb 20267:00 amRNSConfirmation of Chief Executive Officer Start Date
5th Feb 202610:58 amRNSHolding(s) in Company
2nd Feb 20267:01 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSBlock listing Interim Review
23rd Jan 20263:21 pmRNSDirector/PDMR Shareholding
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
23rd Dec 20253:29 pmRNSDirector/PDMR Shareholding
23rd Dec 20253:29 pmRNSDirector/PDMR Shareholding
11th Dec 20251:16 pmRNSConfirmed Financial Calendar
9th Dec 20254:01 pmRNSDirector/PDMR Shareholding
9th Dec 20257:00 amRNSPennon Group CEO Transition Arrangements
1st Dec 20253:42 pmRNSEMTN: Publication of Supplementary Prospectus
1st Dec 20257:00 amRNSTotal Voting Rights
27th Nov 20257:00 amRNSHalf Year Results 2025/26
21st Nov 20254:24 pmRNSDirector/PDMR Shareholding
3rd Nov 20257:00 amRNSTotal Voting Rights
22nd Oct 20251:26 pmRNSDirector/PDMR Shareholding
7th Oct 20257:00 amRNSPennon appoints new Non-Executive Director
3rd Oct 20252:19 pmRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSPennon Group appoints Keith Haslett as new CEO
1st Oct 20257:00 amRNSTotal Voting Rights
26th Sep 20257:00 amRNSTrading Statement
23rd Sep 20254:16 pmRNSDirector/PDMR Shareholding
11th Sep 202512:09 pmRNSEMTN Programme: Publication of Final Terms

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.